PMAIP1 and plasma cell myeloma: The scientists were able to overcome the PI resistance via NOXA induction, which was p53-independent, because its block, using an antisense oligonucleotide, caused a 30% to 50% reduced apoptotic response in melanoma and myeloma cells, suggesting a therapeutic role of agents triggering NOXA induction in these patients [53].